Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Giovanni Guaraldi and Alessandro Cozzi-Lepri.
Giovanni Guaraldi
Connection Strength
1.199
Alessandro Cozzi-Lepri
  1. Re: 'Methodological evaluation of bias in observational COVID-19 studies on drug effectiveness' by Wolkewitz et al. Clin Microbiol Infect. 2021 07; 27(7):1043-1044.
    View in: PubMed
    Score: 0.236
  2. Development and validation of a prediction model for tocilizumab failure in hospitalized patients with SARS-CoV-2 infection. PLoS One. 2021; 16(2):e0247275.
    View in: PubMed
    Score: 0.233
  3. Tocilizumab in COVID-19: finding the optimal route and dose - Authors' reply. Lancet Rheumatol. 2020 Dec; 2(12):e739-e740.
    View in: PubMed
    Score: 0.226
  4. Tocilizumab for severe COVID-19 pneumonia - Authors' reply. Lancet Rheumatol. 2020 Nov; 2(11):e660-e661.
    View in: PubMed
    Score: 0.224
  5. Tocilizumab in patients with severe COVID-19: a retrospective cohort study. Lancet Rheumatol. 2020 Aug; 2(8):e474-e484.
    View in: PubMed
    Score: 0.222
  6. Better prognosis in females with severe COVID-19 pneumonia: possible role of inflammation as potential mediator. Clin Microbiol Infect. 2021 Aug; 27(8):1137-1144.
    View in: PubMed
    Score: 0.058
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.